EDC REX Logo   

 

 News & Events
Valisure Expands Capabilities To Test Medications For Cancer Causing Contaminants Implicated In Recent Recalls        
NDEA and NDMA impurities have been responsible for numerous recalls of hypertension medications and Valisure is now the first pharmacy to test for them in every batch.

In response to the multitude of recalls for angiotensin II receptor blockers (ARB), a sartan class drug that is commonly used to treat high blood pressure, Valisure, the first online Analytical Pharmacy, announced it has expanded its testing capabilities to screen samples from all batches of medications it dispenses for the cancer causing contaminants N-Nitrosodimethylamine (NDMA), N-Nitrosodiethylamine (NDEA), and N,N-Dimethylformamide (DMF), the chemical solvent that has been implicated in the production of these impurities.

Since the beginning of July 2018, the Food and Drug Administration (FDA) has continued to publish recalls in the sartan class of drugs from numerous manufacturers. These common prescription drugs include valsartan, losartan, and irbesartan. Read More 

Facilities update: Put on your hard hats!
Provost Ben Polak sent the following message on March 6 to update members of the campus community on the progress of three major construction projects: the Schwarzman Center, 320 York Street, and the Yale Science Building.

This is a particularly interesting moment in Yale's recent period of physical transformation, with three of our biggest projects slated for completion in the next 18 months. A few weeks ago, I had the chance to visit these three sites - the Schwarzman Center, 320 York Street, and the Yale Science Building - to see the progress first hand and learn from the experts what each project entails.  Read More

CT's 4,000-plus manufacturers try a larger umbrella    
Connecticut is home to more than 4,000 manufacturers, all of varying sizes in terms of sales, staffing and product mix. A small percentage belong to one of more than a half-dozen manufacturing industry trade groups or lobbies.

So many members and lobbies, in fact, industry leaders say, that it's often difficult for them and their industry and legislative allies to know whom to reach out to on issues vital to the manufacturing sector's health and standing.

To be more responsive to issues and inquiries from within and outside the industry, the state's manufacturing participants, with the aid of the Connecticut Business & Industry Association and ConnSTEP, have banded together to create the Connecticut Manufacturers' Collaborative (CMC). Read More

Connecticut Bioscience Pipeline Launches Initial Call for Applications    
The Connecticut Bioscience Pipeline program, a partnership between Connecticut Innovations, the University of Connecticut, Quinnipiac University and Yale University, announced the launch of the first of four open application periods in search of new ideas that can one day become investable business ventures in the medical devices, drug delivery, diagnostics and health IT industries. Eligible projects can qualify for up to $30,000 per team over 12 months to be used for business strategy, market definition and prototyping, and proof-of-concept activities.

Applications for this first round must be submitted by 5:00 p.m. ET on April 26. Read More


Home furnishing retailer coming to Orange shopping plaza Read More 
 
Northeast Alliance Surgery Center Held Ribbon Cutting Ceremony On March 7 And Expects To Start Seeing Patients In April Read More 
 
Economist Kerwin Charles named Yale SOM dean Read More 
 
Plans for new medical complex emerge in North Branford Read More 
 
New Housing, Retail Space to Be Built Near New Haven's Wooster Square Read More